Maria Thomas

2.9k total citations
62 papers, 2.1k citations indexed

About

Maria Thomas is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Maria Thomas has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 18 papers in Oncology and 11 papers in Epidemiology. Recurrent topics in Maria Thomas's work include Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Maria Thomas is often cited by papers focused on Pharmacogenetics and Drug Metabolism (10 papers), Drug Transport and Resistance Mechanisms (10 papers) and Liver Disease Diagnosis and Treatment (9 papers). Maria Thomas collaborates with scholars based in Germany, United States and Italy. Maria Thomas's co-authors include Ulrich M. Zanger, Kathrin Klein, Matthias Schwab, Stefania Bellone, Sërgio Pecorelli, Alessandro D. Santin, Alexander Burnett, Ute Hofmann, Martin J. Cannon and Michela Palmieri and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Bioinformatics.

In The Last Decade

Maria Thomas

61 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Thomas Germany 26 823 422 416 342 266 62 2.1k
Wei Niu China 24 1.2k 1.4× 482 1.1× 174 0.4× 433 1.3× 166 0.6× 71 2.2k
Na Han China 28 1.2k 1.5× 652 1.5× 193 0.5× 151 0.4× 276 1.0× 157 2.6k
Wolfgang Hagmann Germany 23 626 0.8× 637 1.5× 290 0.7× 219 0.6× 177 0.7× 49 2.1k
Claudio D’Amore Italy 29 918 1.1× 854 2.0× 277 0.7× 189 0.6× 455 1.7× 72 2.4k
Juan Carlos García‐Cañaveras Spain 21 1.1k 1.4× 414 1.0× 381 0.9× 148 0.4× 332 1.2× 34 2.0k
Yoshinori Inagaki Japan 28 1.1k 1.3× 416 1.0× 238 0.6× 196 0.6× 402 1.5× 125 2.7k
Lea‐Yea Chuang Taiwan 30 1.2k 1.5× 408 1.0× 153 0.4× 107 0.3× 240 0.9× 106 2.6k
Keith N. Stewart United Kingdom 26 684 0.8× 341 0.8× 426 1.0× 143 0.4× 134 0.5× 75 2.5k
Shu‐Chi Wang Taiwan 23 847 1.0× 367 0.9× 520 1.3× 88 0.3× 180 0.7× 87 1.9k
Rajgopal Govindarajan United States 26 883 1.1× 539 1.3× 147 0.4× 128 0.4× 197 0.7× 49 2.1k

Countries citing papers authored by Maria Thomas

Since Specialization
Citations

This map shows the geographic impact of Maria Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Thomas more than expected).

Fields of papers citing papers by Maria Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Thomas. The network helps show where Maria Thomas may publish in the future.

Co-authorship network of co-authors of Maria Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Thomas. A scholar is included among the top collaborators of Maria Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Thomas. Maria Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Maria, et al.. (2024). Hu14.18K.322A Causes Direct Cell Cytotoxicity and Synergizes with Induction Chemotherapy in High-Risk Neuroblastoma. Cancers. 16(11). 2064–2064. 2 indexed citations
2.
Thomas, Maria, et al.. (2023). SARS‐CoV‐2 vaccination response in pediatric oncology patients. Pediatric Blood & Cancer. 71(2). e30785–e30785. 3 indexed citations
3.
Gaitantzi, H, Maria Thomas, Katja Simon‐Keller, et al.. (2019). Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells. European Surgical Research. 60(1-2). 1–12. 12 indexed citations
4.
Thomas, Maria. (2016). TGF-beta 1 and TGF-beta 2 abundance in liver diseases of mice and men. Oncotarget. 7(15). 3 indexed citations
5.
Luckert, Claudia, Christina Schulz, Maria Thomas, et al.. (2016). Comparative analysis of 3D culture methods on human HepG2 cells. Archives of Toxicology. 91(1). 393–406. 86 indexed citations
6.
Thomas, Maria, Kathrin Klein, Simon Müller, et al.. (2015). The truncated splice variant of peroxisome proliferator-activated receptor alpha, PPARα-tr, autonomously regulates proliferative and pro-inflammatory genes. BMC Cancer. 15(1). 488–488. 24 indexed citations
7.
Ehlting, Christian, Maria Thomas, Ulrich M. Zanger, et al.. (2015). Oncostatin M regulates SOCS3 mRNA stability via the MEK–ERK1/2-pathway independent of p38MAPK/MK2. Cellular Signalling. 27(3). 555–567. 21 indexed citations
8.
Thomas, Maria, et al.. (2015). Activating and Inhibitory Functions of WNT/β-Catenin in the Induction of Cytochromes P450 by Nuclear Receptors in HepaRG Cells. Molecular Pharmacology. 87(6). 1013–1020. 34 indexed citations
9.
Thomas, Maria, Stefan Winter, Miia Turpeinen, et al.. (2015). Peroxisome proliferator-activated receptor alpha, PPARα, directly regulates transcription of cytochrome P450 CYP2C8. Frontiers in Pharmacology. 6. 261–261. 20 indexed citations
10.
Abshagen, Kerstin, et al.. (2015). Foxf1 siRNA Delivery to Hepatic Stellate Cells by DBTC Lipoplex Formulations Ameliorates Fibrosis in Livers of Bile Duct Ligated Mice. Current Gene Therapy. 15(3). 215–227. 17 indexed citations
11.
Lutz, Anna, Maria Thomas, Oliver Sawodny, et al.. (2014). Interleukin-1β Enhances FasL-Induced Caspase-3/-7 Activity without Increasing Apoptosis in Primary Mouse Hepatocytes. PLoS ONE. 9(12). e115603–e115603. 17 indexed citations
12.
Thomas, Maria, Oliver Burk, Benjamin A. Kandel, et al.. (2013). Direct Transcriptional Regulation of Human Hepatic Cytochrome P450 3A4 (CYP3A4) by Peroxisome Proliferator–Activated Receptor Alpha (PPARα). Molecular Pharmacology. 83(3). 709–718. 73 indexed citations
13.
Zanger, Ulrich M., Kathrin Klein, Maria Thomas, et al.. (2013). Genetics, Epigenetics, and Regulation of Drug-Metabolizing Cytochrome P450 Enzymes. Clinical Pharmacology & Therapeutics. 95(3). 258–261. 63 indexed citations
14.
Klein, Kathrin, Maria Thomas, Stefan Winter, et al.. (2012). PPARA: A Novel Genetic Determinant of CYP3A4 In Vitro and In Vivo. Clinical Pharmacology & Therapeutics. 91(6). 1044–1052. 124 indexed citations
15.
16.
High, Whitney A., James F. Ranville, Thomas Horn, et al.. (2008). Cardiac and vascular metal deposition with high mortality in nephrogenic systemic fibrosis. Kidney International. 73(12). 1413–1418. 74 indexed citations
17.
18.
Thomas, Maria, Giridhara R. Jayandharan, & Mammen Chandy. (2006). Molecular screening of the neutrophil elastase gene in congenital neutropenia.. PubMed. 43(12). 1081–4. 1 indexed citations
19.
Toor, Amir A., Jacob Joseph, Maria Thomas, et al.. (2005). Cardiac nonamyloidotic immunoglobulin deposition disease. Modern Pathology. 19(2). 233–237. 27 indexed citations
20.
Santin, Alessandro D., Fenghuang Zhan, Stefania Canè, et al.. (2005). Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapy. British Journal of Cancer. 92(8). 1561–1573. 86 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026